|38.20||+0.0600||+0.16%||Vol 1.51M||1Y Perf -24.71%|
|Apr 19th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||52.58||Analyst Rating||— — 0.00|
|Potential %||37.64||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★+ 49.54|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★ 54.10|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Market Cap||14.98B||Earnings Rating||—|
|Price Range Ratio 52W %||15.60||Earnings Date||10th Jun 2021|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||10th Jun 2021|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||1.45M|
|Avg. Monthly Volume||2.52M|
|Avg. Quarterly Volume||2.27M|
GoodRx Holdings Inc. (NASDAQ: GDRX) stock closed at 38.2 per share at the end of the most recent trading day (a 0.16% change compared to the prior day closing price) with a volume of 1.51M shares and market capitalization of 14.98B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 338 people. GoodRx Holdings Inc. CEO is Douglas Hirsch / Trevor Bezdek.
The one-year performance of GoodRx Holdings Inc. stock is -24.71%, while year-to-date (YTD) performance is -5.3%. GDRX stock has a five-year performance of %. Its 52-week range is between 33.39 and 64.22, which gives GDRX stock a 52-week price range ratio of 15.60%
GoodRx Holdings Inc. currently has a PE ratio of -35.60, a price-to-book (PB) ratio of 21.02, a price-to-sale (PS) ratio of 4.41, a price to cashflow ratio of 79.80, a PEG ratio of 2.32, a ROA of -31.62%, a ROC of 3.43% and a ROE of 156.09%. The company’s profit margin is -53.32%, its EBITDA margin is 13.70%, and its revenue ttm is $550.70 Million , which makes it $8.67 revenue per share.
Of the last four earnings reports from GoodRx Holdings Inc., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. GoodRx Holdings Inc.’s next earnings report date is 10th Jun 2021.
The consensus rating of Wall Street analysts for GoodRx Holdings Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for GoodRx Holdings Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
GoodRx Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
GoodRx Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 21.95, ATR14 : 2.93, CCI20 : -29.84, Chaikin Money Flow : 0.03, MACD : -3.00, Money Flow Index : 57.60, ROC : -2.10, RSI : 35.63, STOCH (14,3) : 34.05, STOCH RSI : 0.37, UO : 44.37, Williams %R : -65.95), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of GoodRx Holdings Inc. in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.